Svetlana T.
- Country
- Croatia
- Department
- Department of Neurology
Research Overview
- Phase 2 Study of (+)-α-Dihydrotetrabenazine for Tardive Dyskinesia in Schizophrenia, Schizoaffective, Mood, Gastrointestinal, or Neuroleptic-Induced Disorders
- Efficacy and Safety Evaluation of DNTH103 in Adults with Chronic Inflammatory Demyelinating Polyneuropathy: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial
Data & Insights
Has run more than one trial at 1 of 70 partner sites.
Specializations
Movement Disorders
The investigator specializes in studying and treating tardive dyskinesia, a significant movement disorder characterized by involuntary muscle movements.
- Movement disorder therapeutics
- Neurological symptom management
Their research encompasses treatment approaches for patients experiencing medication-induced movement complications.
Psychiatric Conditions
The investigator focuses on movement disorders in patients with various psychiatric conditions, including schizophrenia, schizoaffective disorder, and mood disorders.
- Psychiatric therapeutics
- Mental health management
Their work addresses the complex intersection of psychiatric conditions and movement disorders.
Treatment Innovation
The investigator explores novel therapeutic approaches for managing medication-induced disorders, with particular attention to gastrointestinal and neurological complications.
- Therapeutic development
- Treatment optimization
Their research focuses on developing effective treatment strategies for complex neurological conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.